Table 2.
Study | N | Dropouts
|
Baseline HRSD Severity
|
||
---|---|---|---|---|---|
N | % | Mean | SD | ||
Barrett et al. (2001)c | |||||
Placebo | 39 | 8 | 21 | 14.38 | 3.98 |
Medication | 38 | 13 | 34 | 14.05 | 2.86 |
Elkin et al. (1989)c | |||||
Placebo | 62 | 17 | 27 | 19.47 | 4.60 |
Medication | 57 | 13 | 23 | 19.51 | 4.62 |
DeRubeis el al. (2005)b | |||||
Placebo | 60 | 9 | 15 | 23.47 | 2.73 |
Medication | 120 | 13 | 11 | 23.22 | 2.70 |
Dimidjian et al. (2006)b | |||||
Placebo | 45 | 4 | 9 | 20.76 | 4.59 |
Medication | 82 | 15 | 18 | 20.73 | 3.94 |
Philipp et al. (1999)a | |||||
Placebo | 46 | 3 | 7 | 22.20 | 4.15 |
Medication | 105 | 3 | 3 | 22.70 | 4.03 |
Wichers et al. (2009)b,c | |||||
Placebo | 32 | 5 | 16 | 23.72 | 2.81 |
Medication | 32 | 9 | 28 | 24.38 | 3.84 |
Note. Studies with the same superscript do not differ with respect to mean rates of attrition at p < .05.